Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
Add more filters










Publication year range
1.
SLAS Discov ; 23(2): 174-182, 2018 02.
Article in English | MEDLINE | ID: mdl-29020503

ABSTRACT

Aminoacylation has been implicated in a wide variety of cancers. Aminoacyl-tRNA synthetases (ARSs) exist in large excess in tumor cells due to their increased demand for translation, whereas most other protein-synthesis apparatuses are quantitatively limited. Among other components that constitute the translation machinery-namely, tRNA, amino acid, ATP, and ARS-ARS is the only target that can be blocked by small molecules. No constitutively active ARSs have been reported, and mutations of ARS can cause inaccurate substrate recognition and malformation of the multi-ARS complex (MSC). Hence, interference of the activity is expected to be independent of genotype without developing resistance. Here, we report a high-throughput screening (HTS) system to find mammalian ARS inhibitors. The rabbit-reticulocyte lysate we used closely resembles both the individual and complexed structures of human ARSs, and it may predispose active compounds that are readily applicable for humankind. This assay was further validated because it identified familiar translational inhibitors from a pilot screen, such as emetine, proving its suitability for our purpose. The assay demonstrated excellent quality control (QC) parameters and reproducibility, and is proven ready for further HTS campaigns with large chemical libraries.


Subject(s)
Amino Acyl-tRNA Synthetases/antagonists & inhibitors , High-Throughput Screening Assays/methods , Protein Synthesis Inhibitors/pharmacology , Adenosine Triphosphate/metabolism , Amino Acids/metabolism , Aminoacylation/drug effects , Animals , Humans , Mutation/drug effects , Pilot Projects , RNA, Transfer/metabolism , Rabbits , Reproducibility of Results , Reticulocytes/drug effects , Small Molecule Libraries/pharmacology
2.
J Biol Chem ; 292(39): 16014-16023, 2017 09 29.
Article in English | MEDLINE | ID: mdl-28801462

ABSTRACT

Ribosomal translation factors are fundamental for protein synthesis and highly conserved in all kingdoms of life. The essential eukaryotic elongation factor 1A (eEF1A) delivers aminoacyl tRNAs to the A-site of the translating 80S ribosome. Several studies have revealed that eEF1A is posttranslationally modified. Using MS analysis, site-directed mutagenesis, and X-ray structural data analysis of Saccharomyces cerevisiae eEF1A, we identified a posttranslational modification in which the α amino group of mono-l-glutamine is covalently linked to the side chain of glutamate 45 in eEF1A. The MS analysis suggested that all eEF1A molecules are modified by this glutaminylation and that this posttranslational modification occurs at all stages of yeast growth. The mutational studies revealed that this glutaminylation is not essential for the normal functions of eEF1A in S. cerevisiae However, eEF1A glutaminylation slightly reduced growth under antibiotic-induced translational stress conditions. Moreover, we identified the same posttranslational modification in eEF1A from Schizosaccharomyces pombe but not in various other eukaryotic organisms tested despite strict conservation of the Glu45 residue among these organisms. We therefore conclude that eEF1A glutaminylation is a yeast-specific posttranslational modification that appears to influence protein translation.


Subject(s)
Glutamine/metabolism , Models, Molecular , Peptide Elongation Factor 1/metabolism , Protein Processing, Post-Translational , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/metabolism , Amino Acid Sequence , Amino Acid Substitution , Aminoacylation/drug effects , Anti-Infective Agents/pharmacology , Conserved Sequence , Crystallography, X-Ray , Databases, Protein , Gene Expression Regulation, Fungal/drug effects , Glutamic Acid/metabolism , Helix-Loop-Helix Motifs , Mutagenesis, Site-Directed , Mutation , Peptide Elongation Factor 1/chemistry , Peptide Elongation Factor 1/genetics , Protein Processing, Post-Translational/drug effects , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/metabolism , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/growth & development , Saccharomyces cerevisiae Proteins/chemistry , Saccharomyces cerevisiae Proteins/genetics , Sequence Alignment , Species Specificity
3.
J Biomol Screen ; 21(7): 722-8, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27073192

ABSTRACT

The transfer RNA (tRNA)-dependent pathway for lipid aminoacylation is a two-step pathway composed of (1) a tRNA aminoacylation step catalyzed by an aminoacyl-tRNA synthetase, forming a specific aa-tRNA, and (2) a tRNA-dependent transfer step in which the amino acid acylating the tRNA is transferred to an acceptor lipid. The latter step is catalyzed by a transferase located within the cytoplasmic membrane of certain bacteria. Lipid aminoacylation modifies the biochemical properties of the membrane and enhances resistance of some pathogens to various classes of antimicrobial agents and components of the innate immune response. Lipid aminoacylation has also been linked to increased virulence of various pathogenic bacteria. Inhibition of this mechanism would render pathogens more susceptible to existing drugs or to natural defenses of a host organism. Because lipid aminoacylation is widespread in many bacterial genera and absent from eukaryotes, and because the tRNA aminoacylation step of this pathway is also used in protein biosynthesis (a process essential for bacterial life), this pathway represents an attractive target for drug design. We have reconstituted the lipid aminoacylation pathway in vitro and optimized it for high-throughput screening of libraries of compounds to simultaneously identify inhibitors targeting each step of the pathway in a single assay.


Subject(s)
Amino Acyl-tRNA Synthetases/antagonists & inhibitors , Anti-Infective Agents/isolation & purification , Enzyme Inhibitors/isolation & purification , High-Throughput Screening Assays/methods , Amino Acyl-tRNA Synthetases/chemistry , Amino Acyl-tRNA Synthetases/genetics , Aminoacylation/drug effects , Anti-Infective Agents/pharmacology , Cell Membrane/enzymology , Enzyme Inhibitors/pharmacology , Lipids/chemistry , RNA, Transfer/chemistry , Signal Transduction/drug effects , Small Molecule Libraries/analysis , Transferases/antagonists & inhibitors , Transferases/chemistry
4.
Macromol Biosci ; 15(5): 719-27, 2015 May.
Article in English | MEDLINE | ID: mdl-25644632

ABSTRACT

Bombyx mori silk fibroin incorporating three methionine (Met) analogues-homopropargylglycine (Hpg), azidohomoalanine (Aha), and homoallylglycine (Hag)-can be produced simply by adding them to the diet of B. mori larvae. The Met analogues are recognized by methionyl-tRNA synthetase, bound to tRNA(Met), and used for the translation of adenine-uracil-guanine (AUG) codons competitively with Met. In the presence of the standard amount of Met in the diet, incorporation of these analogues remains low. Lowering the amount of Met in the diet drastically improves incorporation efficiencies. Alkyne and azide groups in Hpg and Aha incorporated into silk fibroin can be selectively modified with Cu-catalyzed azide-alkyne cycloaddition reactions (click chemistry). Since Met residues exist only at the N-terminal domain of the fibroin heavy chain and in the fibroin light chain, good access to the reactive sites is expected and domain-selective modifications are possible without perturbing other major domains, including repetitive domains.


Subject(s)
Click Chemistry/methods , Fibroins/chemistry , Methionine/analogs & derivatives , Amino Acid Sequence , Aminoacylation/drug effects , Animals , Bombyx , Larva/drug effects , Methionine/chemistry , Methionine/pharmacology , Molecular Sequence Data , Protein Multimerization/drug effects , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
5.
PLoS One ; 8(11): e79234, 2013.
Article in English | MEDLINE | ID: mdl-24223911

ABSTRACT

Microcin C analogues were recently envisaged as important compounds for the development of novel antibiotics. Two issues that may pose problems to these potential antibiotics are possible acquisition of resistance through acetylation and in vivo instability of the peptide chain. N-methylated aminoacyl sulfamoyladenosines were synthesized to investigate their potential as aminoacyl tRNA synthetase inhibitors and to establish whether these N-alkylated analogues would escape the natural inactivation mechanism via acetylation of the alpha amine. It was shown however, that these compounds are not able to effectively inhibit their respective aminoacyl tRNA synthetase. In addition, we showed that (D)-aspartyl-sulfamoyladenosine (i.e. with a (D)-configuration for the aspartyl moiety), is a potent inhibitor of aspartyl tRNA synthetase. However, we also showed that the inhibitory effect of (D)- aspartyl-sulfamoyladenosine is relatively short-lasting. Microcin C analogues with (D)-amino acids throughout from positions two to six proved inactive. They were shown to be resistant against metabolism by the different peptidases and therefore not able to release the active moiety. This observation could not be reversed by incorporation of (L)-amino acids at position six, showing that none of the available peptidases exhibit endopeptidase activity.


Subject(s)
Amino Acids/chemistry , Amino Acyl-tRNA Synthetases/antagonists & inhibitors , Bacteriocins/chemistry , Bacteriocins/pharmacology , Adenosine/analogs & derivatives , Adenosine/chemistry , Adenosine/pharmacology , Amino Acyl-tRNA Synthetases/chemistry , Amino Acyl-tRNA Synthetases/metabolism , Aminoacylation/drug effects , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Aspartate-tRNA Ligase/antagonists & inhibitors , Aspartate-tRNA Ligase/chemistry , Aspartate-tRNA Ligase/metabolism , Biocatalysis/drug effects , Dose-Response Relationship, Drug , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Escherichia coli/drug effects , Escherichia coli/genetics , Escherichia coli/metabolism , Escherichia coli Proteins/antagonists & inhibitors , Escherichia coli Proteins/chemistry , Escherichia coli Proteins/metabolism , Molecular Structure , Sulfonamides/chemistry , Sulfonamides/pharmacology , Time Factors
6.
Nat Commun ; 4: 1417, 2013.
Article in English | MEDLINE | ID: mdl-23361008

ABSTRACT

Leucyl-tRNA synthetases (LeuRSs) have an essential role in translation and are promising targets for antibiotic development. Agrocin 84 is a LeuRS inhibitor produced by the biocontrol agent Agrobacterium radiobacter K84 that targets pathogenic strains of A. tumefaciens, the causative agent of plant tumours. Agrocin 84 acts as a molecular Trojan horse and is processed inside the pathogen into a toxic moiety (TM84). Here we show using crystal structure, thermodynamic and kinetic analyses, that this natural antibiotic employs a unique and previously undescribed mechanism to inhibit LeuRS. TM84 requires tRNA(Leu) for tight binding to the LeuRS synthetic active site, unlike any previously reported inhibitors. TM84 traps the enzyme-tRNA complex in a novel 'aminoacylation-like' conformation, forming novel interactions with the KMSKS loop and the tRNA 3'-end. Our findings reveal an intriguing tRNA-dependent inhibition mechanism that may confer a distinct evolutionary advantage in vivo and inform future rational antibiotic design.


Subject(s)
Adenine Nucleotides/pharmacology , Agrobacterium tumefaciens/enzymology , Biological Control Agents , Leucine-tRNA Ligase/antagonists & inhibitors , Plant Tumors/microbiology , RNA, Plant/metabolism , RNA, Transfer/metabolism , Adenine Nucleotides/chemistry , Agrobacterium tumefaciens/drug effects , Aminoacylation/drug effects , Calorimetry , Crystallography, X-Ray , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Leucine-tRNA Ligase/chemistry , Leucine-tRNA Ligase/metabolism , Models, Molecular , Protein Binding/drug effects , Protein Conformation , Protein Structure, Tertiary , RNA, Plant/chemistry , RNA, Transfer/chemistry
7.
Ukr Biokhim Zh (1999) ; 84(5): 68-75, 2012.
Article in Russian | MEDLINE | ID: mdl-23342637

ABSTRACT

The influence of the penetrating cryoprotector and Mg2+ ions on the protein-synthesizing activity of postmitochondrial supernantant of the rat liver as well as on aminoacylation processes has been investigated. The addition of the penetrating cryoprotectors--ethylene glycol and DMSO--resulted in the concentration-dependant reversible inhibition of the protein biosynthesis and aminoacylation reaction in the cell-free system. These cryoprotectors at low concentrations intensified the stimulating effect of Mg2+ on the cumulative protein synthesis in the cell-free system.


Subject(s)
Dimethyl Sulfoxide/pharmacology , Ethylene Glycol/pharmacology , Magnesium/pharmacology , Protein Biosynthesis/drug effects , RNA, Transfer/antagonists & inhibitors , Amino Acids/metabolism , Aminoacylation/drug effects , Animals , Cell-Free System , Centrifugation , Chromatography, Gel , Dose-Response Relationship, Drug , Liver/drug effects , Liver/metabolism , Magnesium/metabolism , RNA, Transfer/metabolism , Rats
8.
Vascul Pharmacol ; 56(3-4): 115-21, 2012.
Article in English | MEDLINE | ID: mdl-22155161

ABSTRACT

We hypothesized that under high glucose conditions, activation of the hexosamine pathway leads to impaired nitric oxide (NO)-dependent arteriolar dilation. Skeletal muscle arterioles (diameter: ~160µm) isolated from male Wistar rats were exposed to normal glucose (NG, 5.5mmol/L) or high glucose concentrations (HG, 30mmol/L, for 2h) and agonist-induced diameter changes were measured with videomicroscopy. Western blots were performed to identify the vascular levels of protein O-linked-N-acetyl-glucosamine (O-GlcNAc) and phosphorylated endothelial NO synthase (eNOS). In arterioles exposed to HG, dilations to histamine were abolished compared to those exposed to NG (max: -6±6% and 69±9%, respectively), while acetylcholine-induced responses were not affected. Inhibition of NO synthesis with N(G)-nitro-l-arginine methyl ester (L-NAME) reduced histamine-induced dilations in NG arterioles, but it had no effect on microvessels exposed to HG. Dilations to the NO donor, sodium nitroprusside and constrictions to norepinephrine and serotonin were similar in the two groups. In the presence of the inhibitor of hexosamine pathway, azaserine, histamine-induced dilations were significantly augmented in arterioles exposed to HG (max: 67±2%). Moreover, exposure of vessels to glucosamine (5mmol/L, for 2h) resulted in reduced histamine-induced arteriolar dilations (max: 26±3%). The level of protein O-GlcNAcylation was increased, whereas the P-eNOS (Ser-1177) was decreased in HG exposed vessels. These findings indicate that a high concentration of glucose may lead to glucosamine formation, which impairs histamine-induced, NO-mediated arteriolar dilations. We propose that interfering with the hexosamine pathway may prevent microvascular complications in diabetes.


Subject(s)
Acetylglucosamine/metabolism , Arterioles/metabolism , Hexosamines/metabolism , Hyperglycemia/metabolism , Nitric Oxide/metabolism , Protein Processing, Post-Translational , Vasodilation , Aminoacylation/drug effects , Animals , Arterioles/drug effects , Arterioles/physiopathology , Diabetic Angiopathies/prevention & control , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)/antagonists & inhibitors , Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)/metabolism , Hyperglycemia/physiopathology , In Vitro Techniques , Male , Muscle, Skeletal/blood supply , Nitric Oxide Synthase Type III/antagonists & inhibitors , Nitric Oxide Synthase Type III/metabolism , Phosphorylation/drug effects , Protein Processing, Post-Translational/drug effects , Rats , Rats, Wistar , Vasodilation/drug effects , Vasodilator Agents/pharmacology
9.
PLoS One ; 6(11): e27772, 2011.
Article in English | MEDLINE | ID: mdl-22114689

ABSTRACT

Boron is an essential micronutrient for plants, and it is beneficial for animals. However, at high concentrations boron is toxic to cells although the mechanism of this toxicity is not known. Atr1 has recently been identified as a boron efflux pump whose expression is upregulated in response to boron treatment. Here, we found that the expression of ATR1 is associated with expression of genes involved in amino acid biosynthesis. These mechanisms are strictly controlled by the transcription factor Gcn4 in response to boron treatment. Further analyses have shown that boron impaired protein synthesis by promoting phosphorylation of eIF2α in a Gcn2 kinase dependent manner. The uncharged tRNA binding domain (HisRS) of Gcn2 is necessary for the phosphorylation of eIF2α in the presence of boron. We postulate that boron exerts its toxic effect through activation of the general amino acid control system and inhibition of protein synthesis. Since the general amino acid control pathway is conserved among eukaryotes, this mechanism of boron toxicity may be of general importance.


Subject(s)
Amino Acids/metabolism , Boron/adverse effects , Protein Biosynthesis/drug effects , Saccharomyces cerevisiae/drug effects , Aminoacylation/drug effects , Basic-Leucine Zipper Transcription Factors/genetics , Basic-Leucine Zipper Transcription Factors/metabolism , Biomarkers/metabolism , Blotting, Western , Gene Expression Profiling , Membrane Transport Proteins/genetics , Membrane Transport Proteins/metabolism , Oligonucleotide Array Sequence Analysis , Phosphorylation/drug effects , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , RNA, Messenger/genetics , RNA, Transfer , Real-Time Polymerase Chain Reaction , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae Proteins/metabolism , eIF-2 Kinase/genetics , eIF-2 Kinase/metabolism
10.
J Comb Chem ; 10(3): 391-400, 2008.
Article in English | MEDLINE | ID: mdl-18426239

ABSTRACT

The solid-phase combinatorial synthesis of a new library with potential inhibitory activity against the cytoplasmic lysyl-tRNA synthetase (LysRS) isoform of Trypanosoma brucei is described. The library has been specifically designed to mimic the lysyl adenylate complex. The design was carried out by dividing the complex into four modular parts. Proline derivatives (cis-gamma-amino-L-proline or trans-gamma-hydroxy-L-proline) were chosen as central scaffolds. After primary screening, three compounds of the library caused in vitro inhibition of the tRNA aminoacylation reaction in the low micromolar range.


Subject(s)
Antiprotozoal Agents/chemical synthesis , Combinatorial Chemistry Techniques , Lysine-tRNA Ligase/antagonists & inhibitors , Proline/chemical synthesis , Aminoacylation/drug effects , Animals , Antiprotozoal Agents/pharmacology , Chromatography, High Pressure Liquid/methods , Drug Evaluation, Preclinical , Lysine-tRNA Ligase/chemistry , Lysine-tRNA Ligase/isolation & purification , Molecular Conformation , Proline/analogs & derivatives , Proline/pharmacology , Stereoisomerism , Trypanosoma brucei brucei/enzymology
11.
Nucleic Acids Res ; 36(5): 1654-64, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18263620

ABSTRACT

The selective and potent inhibition of mitochondrial translation in Saccharomyces cerevisiae by pentamidine suggests a novel antimicrobial action for this drug. Electrophoresis mobility shift assay, T1 ribonuclease footprinting, hydroxyl radical footprinting and isothermal titration calorimetry collectively demonstrated that pentamidine non-specifically binds to two distinct classes of sites on tRNA. The binding was driven by favorable entropy changes indicative of a large hydrophobic interaction, suggesting that the aromatic rings of pentamidine are inserted into the stacked base pairs of tRNA helices. Pentamidine binding disrupts the tRNA secondary structure and masks the anticodon loop in the tertiary structure. Consistently, we showed that pentamidine specifically inhibits tRNA aminoacylation but not the cognate amino acid adenylation. Pentamidine inhibited protein translation in vitro with an EC(50) equivalent to that binds to tRNA and inhibits tRNA aminoacylation in vitro, but drastically higher than that inhibits translation in vivo, supporting the established notion that the antimicrobial activity of pentamidine is largely due to its selective accumulation by the pathogen rather than by the host cell. Therefore, interrupting tRNA aminoacylation by the entropy-driven non-specific binding is an important mechanism of pentamidine in inhibiting protein translation, providing new insights into the development of antimicrobial drugs.


Subject(s)
Aminoacylation/drug effects , Anti-Infective Agents/chemistry , Pentamidine/chemistry , Protein Synthesis Inhibitors/chemistry , RNA, Transfer/drug effects , Anti-Infective Agents/pharmacology , Anticodon/chemistry , Base Sequence , Hydrophobic and Hydrophilic Interactions , Molecular Sequence Data , Nucleic Acid Conformation/drug effects , Pentamidine/pharmacology , Protein Biosynthesis/drug effects , Protein Synthesis Inhibitors/pharmacology , RNA, Transfer/chemistry , RNA, Transfer, Leu/chemistry , RNA, Transfer, Leu/drug effects
12.
Mol Biol Cell ; 18(7): 2678-86, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17475781

ABSTRACT

Cytoplasmic tRNAs have recently been found to accumulate in the nucleus during amino acid starvation in yeast. The mechanism and regulation by which tRNAs return to the nucleus are unclear. Here, we show accumulation of cytoplasmic tRNA in the nucleus also occurs during glucose starvation. Nuclear accumulation of tRNA in response to acute glucose or amino acid starvation is rapid, reversible, requires no new transcription, and is independent of the aminoacylation status of tRNA. Gradual depletion of nutrients also results in the accrual of tRNA in the nucleus. Distinct signal transduction pathways seem to be involved in the accumulation of cytoplasmic tRNA in the nucleus in response to amino acid versus glucose starvation. These findings suggest tRNA nucleocytoplasmic distribution may play a role in gene expression in response to nutritional stress.


Subject(s)
Amino Acids/pharmacology , Cell Nucleus/metabolism , Glucose/pharmacology , RNA, Transfer/metabolism , Saccharomyces cerevisiae/drug effects , Active Transport, Cell Nucleus/drug effects , Aminoacylation/drug effects , Carbon/pharmacology , Cell Nucleus/drug effects , Cyclic AMP-Dependent Protein Kinases/metabolism , In Situ Hybridization, Fluorescence , Saccharomyces cerevisiae/cytology , Signal Transduction/drug effects
13.
J Mol Biol ; 369(1): 108-28, 2007 May 25.
Article in English | MEDLINE | ID: mdl-17428498

ABSTRACT

Tryptophanyl-tRNA synthetase (TrpRS) is a functionally dimeric ligase, which specifically couples hydrolysis of ATP to AMP and pyrophosphate to the formation of an ester bond between tryptophan and the cognate tRNA. TrpRS from Bacillus stearothermophilus binds the ATP analogue, adenosine-5' tetraphosphate (AQP) competitively with ATP during pyrophosphate exchange. Estimates of binding affinity from this competitive inhibition and from isothermal titration calorimetry show that AQP binds 200 times more tightly than ATP both under conditions of induced-fit, where binding is coupled to an unfavorable conformational change, and under exchange conditions, where there is no conformational change. These binding data provide an indirect experimental measurement of +3.0 kcal/mol for the conformational free energy change associated with induced-fit assembly of the active site. Thermodynamic parameters derived from the calorimetry reveal very modest enthalpic changes, consistent with binding driven largely by a favorable entropy change. The 2.5 A structure of the TrpRS:AQP complex, determined de novo by X-ray crystallography, resembles that of the previously described, pre-transition state TrpRS:ATP complexes. The anticodon-binding domain untwists relative to the Rossmann-fold domain by 20% of the way toward the orientation observed for the Products complex. An unexpected tetraphosphate conformation allows the gamma and deltad phosphate groups to occupy positions equivalent to those occupied by the beta and gamma phosphates of ATP. The beta-phosphate effects a 1.11 A extension that relocates the alpha-phosphate toward the tryptophan carboxylate while the PPi mimic moves deeper into the KMSKS loop. This configuration improves interactions between enzyme and nucleotide significantly and uniformly in the adenosine and PPi binding subsites. A new hydrogen bond forms between S194 from the class I KMSKS signature sequence and the PPi mimic. These complementary thermodynamic and structural data are all consistent with the conclusion that the tetraphosphate mimics a transition-state in which the KMSKS loop develops increasingly tight bonds to the PPi leaving group, weakening linkage to the Palpha as it is relocated by an energetically favorable domain movement. Consistent with extensive mutational data on Tyrosyl-tRNA synthetase, this aspect of the mechanism develops high transition-state affinity for the adenosine and pyrophosphate moieties, which move significantly, relative to one another, during the catalytic step.


Subject(s)
Adenine Nucleotides/chemistry , Aminoacylation , Geobacillus stearothermophilus/enzymology , Tryptophan-tRNA Ligase/chemistry , Adenosine Triphosphate/pharmacology , Aminoacylation/drug effects , Binding Sites , Catalysis/drug effects , Crystallography, X-Ray , Geobacillus stearothermophilus/drug effects , Magnesium/pharmacology , Molecular Conformation , Protein Binding/drug effects , Static Electricity , Temperature , Thermodynamics
14.
J Mol Evol ; 29(6): 465-74, 1989 Dec.
Article in English | MEDLINE | ID: mdl-2482368

ABSTRACT

If protein synthesis evolved in an RNA world it was probably preceded by simpler processes by means of which interaction with amino acids conferred selective advantage on replicating RNA molecules. It is suggested that, at first, the simple attachment of amino acids to the 2'(3')-termini of RNA templates favored initiation of replication at the end of the template rather than at internal positions. The second stage in the evolution of protein synthesis would probably have been the association of pairs of charged RNA adaptors in such a way as to favor noncoded formation of peptides. Only after this process had become efficient could coded synthesis have begun.


Subject(s)
Biological Evolution , Protein Biosynthesis , RNA/genetics , Adenosine Monophosphate/analogs & derivatives , Adenosine Monophosphate/pharmacology , Aminoacylation/drug effects , Proteins/genetics , RNA/drug effects
17.
Biochim Biophys Acta ; 414(3): 293-308, 1975 Dec 19.
Article in English | MEDLINE | ID: mdl-173393

ABSTRACT

Anaerobic incubation of rabbit reticulocytes at 37 degrees C in Krebs-Ringer solution supplemented with hemin but devoid of glucose resulted at the end of 1-2h in a drastic decline of their ATP content and an attendant arrest of protein synthesis. Subsequent provision of glucose and reoxygenation of the cells was followed by a rapid replenishment of the ATP pool, while resumption of protein synthesis was markedly delayed. This lag period could be considerably reduced by addition of 5-10 mM adenine or 2,6-diaminopurine to the incubation medium. Lysates prepared from ATP-depleted cells exhibited disaggregation of the polysomes and an inhibition of the nedogenously coded protein synthesis, when tested in a cell-free system supplied with an adequate ATP generator. Both alterations increased in severity with the progressive decay of the intracellular ATP pool. The early phase of partial inhibition following a 40-70% decrease of the cellular ATP level was fully reversible by fortifying the cell-free preparation with dithiothreitol or a suitable NADPH-generating system. Aternative, the inhibition could be also overcome by millimolar amounts of adenine, 2,6-diaminopurine and a variety of other purine derivatives or cyclic AMP. The effect of these compounds was unrelated to the endogenous cyclic AMP pool. Joint addition of both dithiothreitol and cyclic AMP or adenine was necessary for relieving the initiation block in lysates derived from cells depleted of 80-90% of their ATP content. On further aggravating the conditions of energy starvation, an additional requirement for phosphorylated sugars, e.g. glucose 6-phosphate or fructose 1,6-diphosphate, became apparent. ATP depletion brought about by exposing the cells to Antimycin A or 2,4-dinitrophenol resulted in a lesion which was indistinguishable from that induced by anaerobic incubation. On the other hand, energy deprivation in cell-free lysates from untreated reticulocytes, preincubated in the absence of an ATP-generating system failed to duplicate the deleterious effect of intracellular ATP depletion. Some aspects bearing on the biochemical mechanism of the lesion and its reversal are discussed in the light of the available data.


Subject(s)
Adenosine Triphosphate/pharmacology , Cyclic AMP/pharmacology , Peptide Chain Initiation, Translational/drug effects , Purines/pharmacology , Sugar Phosphates/pharmacology , Sulfhydryl Compounds/pharmacology , Aminoacylation/drug effects , Animals , Dithiothreitol/pharmacology , Glucose/metabolism , Glucose/pharmacology , Protein Biosynthesis/drug effects , Rabbits , Reticulocytes/drug effects , Reticulocytes/metabolism
18.
J Biol Chem ; 250(23): 9198-205, 1975 Dec 10.
Article in English | MEDLINE | ID: mdl-1194280

ABSTRACT

Intact detergent-washed HeLa nuclei contain a population of polyribisomes that were released by exposure to polyanions such as RNA or poly(U). The released material appeared by electron microscopic examination to be particles averaging about 200 to 300 angstroms in diameter. Sedimentation velocity analysis of the released particles indicated that the particles had S20,w values of 75 and 110. The particles stimulated amino acid incorporation in an ascites S-30 or S-100 extract at 2.5 mM Mg2+. Studies with a variety of antibiotics indicated that these polyribosomes were capable of elongating but not initiating protein synthesis. Although these polyribosomes may be of cytoplasmic origin, they appear unique in that agents thought to disperse chromatin are required for their release from the nucleus.


Subject(s)
Cell Nucleus/ultrastructure , HeLa Cells/ultrastructure , Polynucleotides , Polyribosomes/ultrastructure , RNA , Aminoacylation/drug effects , Animals , Anti-Bacterial Agents/pharmacology , Carcinoma, Ehrlich Tumor/metabolism , Cell Nucleus/metabolism , Cycloheximide/pharmacology , HeLa Cells/metabolism , Kinetics , Male , Mice , Mice, Inbred C57BL , Microscopy, Electron , Neoplasm Proteins/biosynthesis , Polyribosomes/metabolism , Puromycin/pharmacology
19.
Horm Res ; 6(1): 12-9, 1975.
Article in English | MEDLINE | ID: mdl-1158325

ABSTRACT

Insulin is released into the circulation early during fetal life, but the physiological significance of the hormone in the fetus is still unclear. The present study was undertaken to evaluate the possible effects of insulin on the protein metabolism of skeletal and heart muscle during the perinatal period in the rat. When incubating hemidiaphragm in a bicarbonate buffer, 0.1 U/ml ox insulin failed to enhance the incorporation of leucine-4,5-3H into muscle protein before birth and during the immediate neonatal period. From 3 days of age onwards a stimulatory effect of insulin on protein synthesis was constantly observed. While insulin thus was ineffective in promoting protein synthesis in hemidiaphragms before the third postnatal day, it significantly enhanced the synthesis in heart muscle at an earlier stage of development. Insulin stimulated the uptake of alpha-aminoisobutyric acid-1-14C into the diaphragm muscle during late fetal life as well as through the early neonatal period. The role of insulin in protein metabolism during fetal life may thus be limited to the augmentation of amino acid transport in skeletal and heart muscle and to a stimulatory effect on protein synthesis only in certain tissue(s), e.g. heart muscle.


Subject(s)
Aminoacylation/drug effects , Diaphragm/metabolism , Insulin/pharmacology , Muscle Proteins/biosynthesis , Myocardium/metabolism , Protein Biosynthesis/drug effects , Aging , Animals , Animals, Newborn , Diaphragm/drug effects , Diaphragm/growth & development , Female , Fetus , Heart/drug effects , Heart/growth & development , Leucine/metabolism , Muscle Development , Pregnancy , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...